 PAC-1

"This article refers to the anti-tumor molecule, and not the a2iib3 integrin activation specific antibody of the same name"

PAC-1 (first procaspase activating compound) is a synthesized chemical compound that selectively induces apoptosis, in cancerous cells.It was granted orphan drug status by the FDA in 2016.